(HealthDay News) — Women have a higher risk for developing long COVID than men, according to a study published online in JAMA Network Open.

(HealthDay News) — For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes ...

Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study ...

(HealthDay News) — Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study published online in Medicine.

Increased postoperative opioid consumption was associated with higher probability of new persistent opioid use in opioid-naive patients.

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

(HealthDay News) — Time-restricted eating (TRE) may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity, according to a ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).

The weighted number of cancer survivors using medical equipment increased roughly 2.5-fold from 1999 to 2018. The number of US cancer survivors using medical equipment has increased in recent ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...